Erlotiniblet) Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Erlotiniblet) Side Effects
Did You Have Erlotiniblet) Side Effect? |
Erlotiniblet) Side Effects Poll Results |
|
Vote Below:
|
|
Erlotiniblet) Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Erlotiniblet):
What is Your Question? Ask Community:
Daily Health Videos
Erlotiniblet) Side Effects reported on Patientsville.com
None reported at this time.Erlotiniblet) Side Effects reported to FDA
Erlotiniblet) Side Effects Report #5194494-4
Physician from HONG KONG reported Erlotiniblet) side effect on Dec 18, 2006. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotiniblet). After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, duodenal ulcer perforation, malignant neoplasm progression, pneumoperitoneum. Erlotiniblet) dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 02/23/2006.
Erlotiniblet) Side Effects Report #5404265-9
Erlotiniblet) side effect was reported by a Health Professional from UNITED STATES on July 16, 2007. Female patient, 71 years of age, weighting 181.0 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotiniblet). After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, leukopenia, mucosal inflammation, neutrophil count decreased, protein total decreased, pyrexia. Erlotiniblet) dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotiniblet) Side Effects Report #5444139-0
Physician from UNITED STATES reported Erlotiniblet) side effect on Aug 17, 2007. Male patient, 81 years of age, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotiniblet). After drug was administered, patient experienced the following side effects: anorexia, asthenia, blood calcium decreased, blood chloride increased, blood creatinine increased, blood urea increased, dehydration, fatigue, hypernatraemia. Erlotiniblet) dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, INDAPAMIDE, LISINOPRIL, TERAZOSIN, POTASSIUM CHLORIDE, VITAMIN B12, FOLIC ACID. Patient was hospitalized. Patient recovered.